Opioid Analgesic Risk Management Should Not Inhibit Access, Cmte. Says

Risk management plans for opioid analgesics should be modified if it appears the plan inhibits access for the appropriate patient population, FDA's Anesthetic & Life Support Drugs Advisory Committee said